Persistent dysphagia after head and neck radiotherapy: A common and under-reported complication with significant effect on non-cancer-related mortality

Clinical Oncology

Volumn 26, Issue 11, 2014, Pages 697-703

  Szczesniak, M M ^a,b   Maclean, J ^a   Zhang, T ^a,b   Graham, P H ^a   Cook, I J ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dysphagia; Head and neck; Mortality; Prevalence; Radiotherapy

Indexed keywords

ARTICLE; ASPIRATION PNEUMONIA; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONCANCER RELATED MORTALITY; SYDNEY SWALLOW QUESTIONNAIRE; ADVERSE EFFECTS; CANCER STAGING; CLINICAL TRIAL; COMPLICATION; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; INTENSITY MODULATED RADIATION THERAPY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION INJURIES; RETROSPECTIVE STUDY; SURVIVAL RATE; SWALLOWING;

CROSS-SECTIONAL STUDIES; DEGLUTITION; DEGLUTITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84908071324     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.08.009     Document Type: Article

References (39)

1. Cancer in Australia: an overview 2008. Cancer Series no. 46. Canberra, 2008.
2. Souhami R., Tobias J. Cancer and its management 2005, Blackwell Publishing, Malden. 5th ed.
3. Tracey E., Baker D., Chen W., Stavrou E., Bishop J. Cancer in New South Wales: incidence, mortality and prevalence, 2005 2007, Cancer Institute NSW, Sydney.
4. The Department of Veterans Affairs Laryngeal Cancer Study Group, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. New Engl J Med 1991, 324:1685-1690.
5. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88:890-899.
6. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer [see comment]. New Engl J Med 2003, 349:2091-2098.
7. Mittal B.B., Pauloski B.R., Haraf D.J., et al. Swallowing dysfunction - preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003, 57:1219-1230.
8. Cooper J.S., Fu K., Marks J., Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995, 31:1141-1164.
9. Langendijk J.A., Doornaert P., Verdonck-de Leeuw I.M., Leemans C.R., Aaronson N.K., Slotman B.J. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008, 26:3770-3776.
10. Nguyen N.P., Moltz C.C., Frank C., et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 2004, 15:383-388.
11. List M.A., Siston A., Haraf D., et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999, 17:1020-1028.
12. Al-Othman M.O., Amdur R.J., Morris C.G., Hinerman R.W., Mendenhall W.M. Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer?. Head Neck 2003, 25:741-747.
13. Platteaux N., Dirix P., Dejaeger E., Nuyts S. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia 2010, 25:139-152.
14. Thames H.D., Bentzen S.M., Turesson I., Overgaard M., Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 1990, 19:219-235.
15. Lazarus C.L., Logemann J.A., Pauloski B.R., et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996, 106:1157-1166.
16. Jensen K., Lambertsen K., Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007, 85:74-82.
17. Berger P.S., Bataini J.P. Radiation-induced cranial nerve palsy. Cancer 1977, 40:152-155.
18. Eisele D.W., Koch D.G., Tarazi A.E., Jones B. Case report: aspiration from delayed radiation fibrosis of the neck. Dysphagia 1991, 6:120-122.
19. Wallace K.L., Middleton S., Cook I.J. Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology 2000, 118:678-687.
20. Dwivedi R.C., St Rose S., Roe J.W., et al. Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral Oncol 2010, 46:e10-e14.
21. Szczesniak M.M., Maclean J., Zhang T., Liu R., Cook I.J. The normative range for and age and gender effects on the Sydney Swallow Questionnaire (SSQ). Dysphagia 2014, [Epub ahead of print]. 10.1007/s00455-014-9541-x.
22. Pauloski B.R., Rademaker A.W., Logemann J.A., et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 2000, 22:474-482.
23. Corbo M., Balmaceda C. Peripheral neuropathy in cancer patients. Cancer Invest 2001, 19:369-382.
24. Gillette E.L., Mahler P.A., Powers B.E., Gillette S.M., Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 1995, 31:9.
25. Epstein J.B., Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol 2010, 46:77-81.
26. Porter S.R., Fedele S., Habbab K.M. Taste dysfunction in head and neck malignancy. Oral Oncol 2010, 46:457-459.
27. Mossman K.L., Henkin R.I. Radiation-induced changes in taste acuity in cancer patients. Int J Radiat Oncol Biol Phys 1978, 4:663-670.
28. Mossman K.L. Gustatory tissue injury in man: radiation dose response relationships and mechanisms of taste loss. Br J Cancer Suppl 1986, 7:9-11.
29. Mossman K., Shatzman A., Chencharick J. Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys 1982, 8:991-997.
30. Fujimoto Y., Ozawa K., Miyake M., Ando A., Nakashima T. Radiotherapy lowers laryngeal sensation: and endoscopic investigation (Abstract). Dysphagia 2009, 24:449.
31. Pauloski B.R., Rademaker A.W., Logemann J.A., et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 2002, 24:555-565.
32. Smith C.H., Logemann J.A., Colangelo L.A., Rademaker A.W., Pauloski B.R. Incidence and patient characteristics associated with silent aspiration in the acute care setting. Dysphagia 1999, 14:1-7.
33. Wu C.H., Hsiao T.Y., Ko J.Y., Hsu M.M. Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000, 109:320-325.
34. Purkey M.T., Levine M.S., Prendes B., Norman M.F., Mirza N. Predictors of aspiration pneumonia following radiotherapy for head and neck cancer. Ann Otol Rhinol Laryngol 2009, 118:811-816.
35. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006, 66:981-991.
36. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007, 25:4873-4879.
37. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136.
38. Bhide S.A., Newbold K.L., Harrington K.J., Nutting C.M. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol 2012, 85:487-494.
39. Hall E.J., Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88.